AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort

Nuseibah Rahahlah, Zina Al-Alami, Mohammed S. Alorjani, Asmaa Al-Smadi, Sewar Obeidat, Raed Otoom, Raed M. Al-Zoubi, Samir Al Bashir, Mazhar Salim Al Zoubi

Open source

DOI
10.3390/ijms27104228
Published
2026-05-09
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms27104228,
  title = {AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort},
  author = {Nuseibah Rahahlah and Zina Al-Alami and Mohammed S. Alorjani and Asmaa Al-Smadi and Sewar Obeidat and Raed Otoom and Raed M. Al-Zoubi and Samir Al Bashir and Mazhar Salim Al Zoubi},
  year = {2026},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms27104228},
  url = {https://doi.org/10.3390/ijms27104228}
}

RIS

TY  - JOUR
TI  - AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort
AU  - Nuseibah Rahahlah
AU  - Zina Al-Alami
AU  - Mohammed S. Alorjani
AU  - Asmaa Al-Smadi
AU  - Sewar Obeidat
AU  - Raed Otoom
AU  - Raed M. Al-Zoubi
AU  - Samir Al Bashir
AU  - Mazhar Salim Al Zoubi
PY  - 2026
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27104228
UR  - https://doi.org/10.3390/ijms27104228
ER  - 

APA

Rahahlah, N., Al-Alami, Z., Alorjani, M. S., Al-Smadi, A., Obeidat, S., Otoom, R., Al-Zoubi, R. M., Bashir, S. A., & Zoubi, M. S. A. (2026). AKT2 Exon 3 Variants and Their Prevalence in Prostate Cancer Patients: Insights from a Jordanian Clinical Cohort. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27104228

Source records